je.st
news
CHMP Issues Positive Opinion for Tablet Formulation of Merck's NOXAFIL
2014-03-01 00:42:42| Biotech - Topix.net
Merck , known as MSD outside the United States and Canada, announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency recipients with graft-versus-host disease or those with hematologic malignancies with prolonged neutropenia from chemotherapy.
Tags: issues
positive
opinion
formulation
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||